Research 2004

Department Home

Researchers

Guest Researchers

Research Interests

Research Output

Postgraduate Student Projects 2004

Research Findings

Funded Projects

Back To

Researchers

 

Faculty of Health Sciences
School of Medicine
Department of Pharmacology

Van Rensburg-Medlen, CEJ

MSc(Pret) PhD(Pret) - Professor

NRF Rating: B3

Contact Details

Research Interests

Research Output

Contact Details:

Telephone number: 012 319 2622
Fax number: 012 323 0732
E-mail address: cmedlen@med.up.ac.za

Research Interests:

Medicinal plant research

Immunopharmacology including respiratory pharmocology

Development of anti-cancer agents

Research Output:

Research articles in refereed specialist journals:

Michie J, Akudugu J, Binder A, Van Rensburg-Medlen CEJ, Böhm L: 2004. Flow cytrometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity. Anticancer Research, 23, pp 2675-2680.

Weber B, Serafin A, Michie J, Van Rensburg-Medlen CEJ, Swarts JC, Böhm L: 2004. Cytotoxicity and cell death pathways invoked by two new Rhodium-Ferrocene complexes in benign and malignant prostatic cell lines. Anticancer Research, 24, pp 763-770.

Joone GK, Van Rensburg-Medlen CEJ: 2004. An in vitro investigation of the anti-inflammatory properties of Potassium Humate. Inflammation, 28 (3) / Jun, pp 169-174.

Fernandez AC, Cromarty AD, Albrecht C, Van Rensburg-Medlen CEJ: 2004. The antioxidant potential of Sutherlandia frutescens. Journal of Ethnopharmacology, 95, pp 1-5.

Steenkamp V, Mathivha E, Gouws MC, Van Rensburg-Medlen CEJ: 2004. Studies on antibacterial, antioxidant and fibroblast growth stimulation of wound healing remedies from South Africa. Journal of Ethnopharmacology, 95, pp 353-357.

Steenkamp V, Fernandez AC, Van Rensburg-Medlen CEJ: 2004. Antioxidant scavenging potential of South African export herbal teas. South African Journal of Botany, 70 (4), pp 660-663.

Patents:

Swarts JC, Van Rensburg-Medlen CEJ: 2004. Ferrocene Compounds: A substance or composition for the treatment of cancer. (PCT/IBO 1/02258).

 

Related Links

Department of Pharmacology Home Page

NRF Rating Information